Active ingredientAclidinium BromideCat. No. P-A032-001CAS 320345-99-1Family · Pharmaceutical analytical standards
Aclidinium
A long-acting inhaled muscarinic antagonist (LAMA): by blocking M3 receptors in the airways it relaxes their muscle. It was approved in the US in 2012 for maintenance treatment of chronic obstructive pulmonary disease (COPD). This family brings together the active ingredient and other impurities.
Did you know?In the blood it splits quickly, partly even without enzymes, into an acid and an alcohol: less than 5% of the inhaled amount reaches the plasma unchanged, yet in the airways it acts for more than 24 hours.
Go to the active ingredient →Active ingredientAclidinium BromideCat. No. P-A032-001CAS 320345-99-1
ImpurityAclidinium Bromide 3S-IsomerCat. No. P-A032-002
ImpurityAclidinium Impurity 1Cat. No. P-A032-003
ImpurityAclidinium Impurity 2Cat. No. P-A032-004
ImpurityAclidinium Impurity 3Cat. No. P-A032-005No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.